Start Submission

Reading: Tracking the evolution of NAFLD through a non-invasive lipidomic test that accurately discri...

Download

A- A+
Alt. Display

Conference/Meeting Abstract Proceedings

Tracking the evolution of NAFLD through a non-invasive lipidomic test that accurately discriminates NASH from steatosis

Authors:

Cristina Alonso ,

OWL, Derio, Bizkaia, Spain, ES
X close

M Concepción García,

Department of Digestive Disease, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain, ES
X close

Beatriz Antolín,

Department of Digestive Disease, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain, ES
X close

Natalia Mora,

Department of Digestive Disease, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain, ES
X close

Itziar Mincholé,

OWL, Derio, Bizkaia, Spain, ES
X close

Ibon Martínez-Arranz,

OWL, Derio, Bizkaia, Spain, ES
X close

Daniel A de Luis,

Institute of Endocrinology and Nutrition, Medicine School and Department of Endocrinology and Nutrition, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain, ES
X close

Rocío Aller

Department of Digestive Disease, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain; Institute of Endocrinology and Nutrition, Medicine School and Department of Endocrinology and Nutrition, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain, ES
X close

Abstract

How to Cite: Alonso, C. et al., (2017). Tracking the evolution of NAFLD through a non-invasive lipidomic test that accurately discriminates NASH from steatosis. New Horizons in Clinical Case Reports. 1, pp.17–18. DOI: http://doi.org/10.1016/j.nhccr.2017.06.174
2
Views
Published on 07 Sep 2017.
Peer Reviewed

Downloads

  • PDF (EN)